Press Releases

Notable Milestones for the Company's Programs VANCOUVER, Nov. 26, 2019 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA: P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to provide an update to shareholders.Today RepliCel anno

MADISON, Wis., Nov. 26, 2019 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will be participating in the following investor conference.

INDIANAPOLIS, Nov. 26, 2019 /PRNewswire/ -- iSalus Healthcare, in an effort to continue improving the workflow efficiencies of its partners, announced a collaboration with CoverMyMeds to integrate its leading prescription price transparency and electronic prior authorization (ePA) solutions into iSalus' cloud-based practice management and electronic health record (E

CHICAGO, Nov. 26, 2019 /PRNewswire/ -- A procedure that applies pulses of focused ultrasound to the brain is safe and effective for reducing tremors and improving quality of life in people with essential tremor (ET) or Parkinson's disease (PD) tremor, according to a new study being presented next week at the annual meeting of the Radiological Society of

CHICAGO, Nov. 26, 2019 /PRNewswire/ -- Cancers found in patients undergoing annual mammography screening are smaller and less advanced than those found in patients undergoing screenings every two years, according to a new study presented next week at the annual meeting of the Radiological Society of North America (RSNA).Breast

LUND, Sweden, Nov. 26, 2019 /PRNewswire/ -- Camurus announced today topline results from the 24-week, randomized, controlled, open-label, DEBUT study of weekly and monthly Buvidal® (prolonged-release buprenorphine) versus standard of care with daily sublingual buprenorphine (e.g. Suboxone® Film) in 120 randomized outpatients at

RADNOR, Pa., Nov. 25, 2019 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that the firm has filed a securities fraud class action lawsuit against Baxter International Inc. (NYSE: BAX) ("Baxter") on behalf investors who purchased or otherwise acquired Baxter common stock between February 21, 2019 and

TOKYO, Nov. 25, 2019 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that the China National Medical Products Administration (NMPA) approved a new drug application (NDA) for XTANDI® (enzalutamide) on November 18 for the t

FREMONT, Calif. and TOKYO, Nov. 25, 2019 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing first-in-class medicines to improve treatment for people with cardiorenal diseases and Kyowa Kirin Co., Ltd., (TSE:4151, President and CEO: Masashi Miyamoto

SILVER SPRING, Md., Nov. 25, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved a new system for the delivery of tympanostomy tubes, commonly referred to as ear tubes, that can be inserted into the eardrum to treat recurrent ear infections (i.e., otitis media). The Tubes Under Local Anesthesia (Tula) System is the first ear tube delivery system tha